newsfilter
← Latest News
Business Wire·

C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology

C-Further to advance its first two bespoke paediatric cancer therapeutics in collaboration with leading global academic and industry investigators Selected programmes to potentially address multiple children's cancers